Analyzing the Spatial Distribution of Immune Cells in Lung Adenocarcinoma
Florina Almarii1,2, Maria Sajin2,3, George Simion3
1Department of Pathology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Journal of Personalized Medicine
|September 28, 2024
Summary
This study reveals key immune cell interactions in lung adenocarcinoma, showing PD-L1 expression correlates with specific immune cells. Understanding this spatial immune profile can guide immunotherapy selection for patients.
Area of Science:
- Oncology
- Immunology
- Pathology
Background:
- Investigating the tumor immune microenvironment is crucial for understanding lung adenocarcinoma.
- Focus on immune cell distribution within the tumor microenvironment.
Purpose of the Study:
- To analyze immune cell distribution and correlations with PD-L1 expression in lung adenocarcinoma.
- To explore spatial heterogeneity of the immune landscape within tumors.
Main Methods:
- Evaluated 50 lung adenocarcinoma cases using tissue microarrays.
- Stained sections for H&E, CD68, CD163, CD8, CD4, and PD-L1.
- Compared immune cell components between tumor center and periphery.
Main Results:
- Significant correlations found between PD-L1 expression and CD163+ macrophages.
- Correlations identified between CD4+ cells and CD8+, CD68+, CD163+ cells.
- Spatial heterogeneity in immune cell correlations with PD-L1 noted between tumor regions.
Conclusions:
- Highlights complex immune cell and tumor cell interactions in lung adenocarcinoma.
- Suggests patient spatial immune profiling can optimize immunotherapy selection.
- Aims to improve patient outcomes by identifying those most likely to respond to immunotherapy.
